Efficacy Study Measuring the Impact of Pregabalin on Peripheral Neuropathic Pain.

Summary

This study will measure the impact of treatment with pregabalin in adult men and women who have a diagnosis of peripheral neuropathic pain (pain caused by a primary lesion of the peripheral nervous system such as Diabetic peripheral Neuropathy and Postherpetic Neuralgia).

Timeline

Start

2005-11

Primary completion

2008-02

Completion

2008-02

Outcome

Met primary endpoint

registry analysis (unspecified test); Pregabalin vs Placebo; p = 0.0018; Mean Difference (Net) -0.78 (95% CI -1.27 to -0.30); ANCOVA NCT00219544 ↗

Drugs

Indications